Pharma Development Partner
Transforming Pharmaceuticals Development
The Mimer platform helps pharma companies develop drugs faster and more effectively. It improves how new therapies are discovered, validated, and brought to market, reducing trial failures and supporting personalized treatments.
Mimer platform
MIMER analyzes genome and transcriptome data, along with research and public datasets, to find new gene interactions and drug targets. Sharing data with pharmaceutical partners speeds up their innovation and makes clinical trials more efficient.
How it works
Optimized clinical trial designs and accelerated drug approval processes
1
OF
#
Drug Repurposing
MIMER analyzes overlapping disease mechanisms and gene signatures to suggest new uses for existing drugs, accelerating market entry and reducing development time and costs.
2
OF
#
Target Discovery
MIMER identifies novel cellular pathways and tissue-specific genes, uncovering new therapeutic targets for precise and effective drug development, and correlates these with existing drug targets for new opportunities.
3
OF
#
Approval Catalyst
Using AI and big data analytics, MIMER suggests mechanisms of action for experimental drugs in late-stage development, providing insights into efficacy and safety to facilitate regulatory approval.
4
OF
#
Patient Stratification
MIMER stratifies patients based on genetic and molecular profiles, identifying those likely to respond well to specific drugs, optimizing clinical trial designs, and enhancing trial success rates.
Join us in shaping a healthier, more predictable future through innovation, clinical insights, and cutting-edge solutions. Together, we can unlock the future of precision medicine and transform the way we treat diseases.
Personalized Precision Treatment Support
M Platform
The M-Platform provides healthcare professionals with precise treatment recommendations.